TYK Medicines Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-	-382.43	-310.99
Depreciation & Amortization	-	27.64	16.33
Other Amortization	-	8	-
Loss (Gain) From Sale of Assets	-	0.01	0.04
Loss (Gain) From Sale of Investments	-	0.73	-0.34
Stock-Based Compensation	-	3.89	-
Other Operating Activities	-	90.17	76.57
Change in Accounts Receivable	-	-11.27	-19.6
Change in Accounts Payable	-	62.32	-4.89
Change in Other Net Operating Assets	-	-	22.83
Operating Cash Flow	-	-200.94	-220.05
Capital Expenditures	-	-76.38	-58.97
Sale of Property, Plant & Equipment	-	0.07	0
Sale (Purchase) of Intangibles	-	-0.88	-29.21
Investment in Securities	-	149.03	-64.15
Other Investing Activities	-	1.17	-5.84
Investing Cash Flow	-	73.01	-158.17
Long-Term Debt Repaid	-	-16.48	-1.61
Net Debt Issued (Repaid)	-	-16.48	-1.61
Issuance of Common Stock	-	185	325
Other Financing Activities	-	55.47	27.75
Financing Cash Flow	-	224	351.14
Foreign Exchange Rate Adjustments	-	0.01	-
Net Cash Flow	-	96.07	-27.08
Free Cash Flow	-	-277.32	-279.02
Free Cash Flow Margin	-	-	-630.67%
Free Cash Flow Per Share	-	-0.96	-1.00
Levered Free Cash Flow	-	94.34	-
Unlevered Free Cash Flow	-	99.8	-
Change in Net Working Capital	1,228	-330.37	-

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.